Stock listing
NASDAQ:JNCE Jounce Therapeutics Inc Stock
Follow Jounce Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:JNCE
$1.88 USD
Close on May 5, 2023 · No longer trades
- Lowest – highest close
- $0.64 – $28.46 USDSince Jan 26, 2017 · lowest Dec 12, 2022 · highest May 1, 2017
Delisted NASDAQ:JNCE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:JNCE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Jounce Therapeutics Inc on 6ix
- Calls
- 7 calls with a replay · 7 with a transcript · latest Nov 10, 2022
- Decks
- 13 decks · latest Aug 30, 2022
Events
| Call | When | Status |
|---|---|---|
| Jounce Therapeutics (JNCE) Q3 2022 Earnings Call | Thu, Nov 10, 2022 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q2 2022 Earnings Call | Thu, Aug 04, 2022 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q1 2022 Earnings Call | Thu, May 05, 2022 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q4 2021 Earnings Call | Wed, Mar 02, 2022 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 8:00 AM ET | Replay |
| Jounce Therapeutics (JNCE) Q1 2021 Earnings Call | Tue, May 04, 2021 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2022) | Investor deck | 34 slides | Aug 30, 2022 |
| Investor Presentation (March 2022) | Investor deck | 33 slides | Mar 7, 2022 |
| Investor Presentation (January 2022) | Investor deck | 31 slides | Jan 10, 2022 |
| Investor Presentation (January 2021) | Investor deck | 26 slides | Jan 11, 2021 |
| Investor Presentation (April 2020) | Investor deck | 28 slides | Apr 7, 2020 |
| Investor Presentation (January 2020) | Investor deck | 26 slides | Jan 13, 2020 |
| Investor Presentation (September 2019) | Investor deck | 22 slides | Sep 4, 2019 |
| Investor Presentation (January 2019) | Investor deck | 25 slides | Jan 7, 2019 |
| Investor Presentation (November 2018) | Investor deck | 29 slides | Nov 9, 2018 |
| 2018 American Society of Clinical Oncology Annual Meeting | Conference | 24 slides | Jun 5, 2018 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (June 2018) | Technical | 18 slides | Jun 4, 2018 |
| Investor Presentation (January 2018) | Investor deck | 25 slides | Jan 8, 2018 |
| AACR Annual Meeting 2017 | Conference | 27 slides | Apr 3, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Barbara Duncan Other companies: Halozyme Therapeutics, Inc. (Director · Since at least Feb 3, 2023); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); Ovid Therapeutics Inc. (Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee · Since at least Jun 14, 2017); Fusion Pharmaceuticals Inc (Director · Oct 30, 2020 – Jun 4, 2024 · Past); Immunomedics Inc (Director · Mar 5, 2019 – Oct 23, 2020 · Past); Innoviva, Inc. (Director · Nov 18, 2016 – Apr 20, 2017 · Past); Adaptimmune Therapeutics PLC (Director · Jun 23, 2016 – Jul 1, 2022 · Past); Aevi Genomic Medicine LLC (Director · Jul 22, 2015 – Feb 3, 2020 · Past); Intercept Pharmaceuticals Inc (Chief Accounting Officer · Oct 10, 2012 – Oct 3, 2016 · Past) | Director · Jan 26, 2017 – May 3, 2023 · Past |
| Perry A Karsen Other companies: LENZ Therapeutics, Inc. (Director · Jan 13, 2021 – Jul 19, 2023 · Past); Jiya Acquisition Corp (Director · Nov 18, 2020 – Nov 18, 2020 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – Dec 17, 2020 · Past); OncoMed Pharmaceuticals Inc (Director · Jan 4, 2016 – Apr 23, 2019 · Past); Voyager Therapeutics, Inc. (Director · Nov 10, 2015 – Jun 13, 2019 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Jun 23, 2015 · Past); Celgene Corporation (see remarks · Feb 15, 2012 – Dec 31, 2015 · Past) | Director · Jan 26, 2017 – May 3, 2023 · Past |
| Robert I Tepper Other companies: Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jun 6, 2019 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Jun 5, 2019 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jul 25, 2017 · Past); Dare Bioscience, Inc. (Director · Apr 10, 2014 – Jun 26, 2015 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Feb 3, 2015 · Past); Millennium Pharmaceuticals Inc (President, R&D · Sep 15, 2005 – Feb 12, 2007 · Past) | Director · Jan 26, 2017 – Jun 26, 2020 · Past |
| Robert Iannone Other companies: Pliant Therapeutics, Inc. (Director · Since at least Jul 9, 2026); Autolus Therapeutics plc (Chair of the Research & Development Committee · Since at least Mar 18, 2026); Jazz Pharmaceuticals plc (EVP, Global Head of R&D & CMO · Since at least May 29, 2019); Iteos Therapeutics Inc (Director · Apr 29, 2021 – Jun 11, 2024 · Past); Immunomedics Inc (CHIEF MEDICAL OFFICER · Apr 12, 2018 – Mar 14, 2019 · Past) | Director · Jan 21, 2020 – May 3, 2023 · Past |
| Kimberlee C. Drapkin Other companies: Climb Bio, Inc. (Director · Since at least Mar 28, 2025); LENZ Therapeutics, Inc. (Member · Since at least Jul 28, 2023); Acumen Pharmaceuticals, Inc. (Director · Since at least Apr 1, 2022); Kineta Inc. (Director · Since at least Feb 1, 2019) | President, CFO and Treasurer · Jan 26, 2017 – May 3, 2023 · Past |
| Kevin Tang Other companies: Aurinia Pharmaceuticals Inc (Chair of the Board and Chief Executive Officer · Since at least Sep 12, 2024); Heron Therapeutics, Inc. (Director · Dec 22, 2015 – Dec 31, 2019 · Past); La Jolla Pharmaceutical Co (Director · Aug 19, 2015 – Aug 22, 2022 · Past) | Director · May 3, 2023 – May 3, 2023 · Past |
| Hugh M Cole Other companies: Astria Therapeutics Inc (Director · Since at least Jul 26, 2019); Ariad Pharmaceuticals Inc (SVP, Chief Business Officer · Apr 29, 2016 – Feb 16, 2017 · Past) | Chief Operating Officer · Dec 20, 2017 – Jan 9, 2023 · Past |
| Cary Pfeffer Other companies: Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – Jun 8, 2016 · Past) | Director · Jan 26, 2017 – Nov 12, 2021 · Past |
| Elizabeth Trehu Other companies: Constellation Pharmaceuticals Inc (Director · Sep 4, 2018 – Jul 15, 2021 · Past) | Chief Medical Officer · Jan 26, 2017 – Jan 9, 2023 · Past |
| Jigar Raythatha Other companies: Constellation Pharmaceuticals Inc (See Remarks, Director · Jul 18, 2018 – Jul 15, 2021 · Past) | Director · Sep 13, 2021 – May 3, 2023 · Past |
All 15 people
| Person | Seat |
|---|---|
| John Duncan Higgons Other companies: Agios Pharmaceuticals, Inc. (Chief Operating Officer · Jul 23, 2013 – Jan 4, 2016 · Past) | Director · Jan 26, 2017 – Jun 24, 2022 · Past |
| Luis A. Diaz Other companies: Quest Diagnostics Incorporated (Director · Since at least May 17, 2023) | Director · Oct 20, 2017 – May 3, 2023 · Past |
| Luisa Salter-Cid Other companies: Gossamer Bio, Inc. (Chief Scientific Officer · Feb 7, 2019 – Mar 23, 2021 · Past) | Director · Feb 10, 2021 – May 3, 2023 · Past |
| Richard /CA/ Murray Other companies: PDL BioPharma Inc (EVP & CSO · Mar 3, 2006 – Jul 21, 2008 · Past) | Director · Jan 26, 2017 – May 3, 2023 · Past |
| Robert Kamen | Director · Jan 26, 2017 – May 3, 2023 · Past |
Log in to ask 6ix AI your own questions about Jounce Therapeutics Inc.